KORB MARK JOHN 4
4 · Icagen, Inc. · Filed Nov 16, 2018
Insider Transaction Report
Form 4
Icagen, Inc.NONE
KORB MARK JOHN
Chief Financial Officer
Transactions
- Award
Stock Option
2018-11-14+100,000→ 100,000 totalExercise: $3.50From: 2018-11-14Exp: 2028-11-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests as to all 100,000 shares of common stock immediately.